Health & Biotech

Health & Biotech

Health: Botanix shares fall 50% after failed clinical trial

11 hours agoOctober 23, 2019 | Nick Sundich

Health & Biotech

Dr Boreham’s Crucible: the story of Clinuvel, an Australian triumph

October 20, 2019October 20, 2019 | Tim Boreham

Health & Biotech

Health: Noxopharm reckons its cancer-fighting Veyonda treatment could be a winner for late-stage patients

October 21, 2019October 21, 2019 | Sam Jacobs

Health & Biotech

With M&A heating up in Aus cannabis, is it international land grab time?

October 17, 2019October 17, 2019 | Daniel Paproth

Health & Biotech

Investors flocking to Melbourne for southern hemisphere’s biggest biotech investment conference

October 17, 2019October 17, 2019 | Daniel Paproth

Health & Biotech

Health: the hits keep coming for Avecho Biotechnology

October 17, 2019October 17, 2019 | Daniel Paproth

Health & Biotech

Cannabis: THC just got those long-awaited narcotics licenses

October 17, 2019October 17, 2019 | Nick Sundich

Health & Biotech

Building a sustainable biotech sector in WA

October 17, 2019October 17, 2019 | Bevis Yeo

Health & Biotech

Check-up: Takeover bid puts workplace health solutions provider Konekt on top

October 16, 2019October 16, 2019 | Daniel Paproth

Health & Biotech

The Health Kick Podcast with Tim Boreham: Anatara Lifesciences

October 16, 2019October 16, 2019 | Tim Boreham

Health & Biotech

The life sciences investment wave is building. Here’s how to ride it.

October 16, 2019October 16, 2019 | Brian Robins

Health & Biotech

600 prescriptions have now been written for MGC Pharma medicinal cannabis products

October 16, 2019October 17, 2019 | Special Report